Many people with type 1 diabetes (T1D) are not meeting recommended glycemic targets across all ages and demographic populations, contributing to the immense burden on those living with diabetes and their families.1–5 The relatively recent introduction of automated insulin delivery (AID) systems has shown promising results for improving glycemic outcomes for people with diabetes, with several systems now available in the United States and Europe.6–10. Here, INS is linked to diabetes mellitus.